Idiosyncratic adverse drug reactions: Current concepts

Pharmacological Reviews

Volumn 65, Issue 2, 2013, Pages 779-808

  Uetrecht, Jack ^a   Naisbitt, Dean J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BETA LACTAM ANTIBIOTIC; DRUG; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; PARACETAMOL; PENICILLAMINE; PHENYLENEDIAMINE; PROTEIN; SULFAMETHOXAZOLE; SUPEROXIDE DISMUTASE; ANTIINFECTIVE AGENT; BETA LACTAM; CYTOKINE; SULFONAMIDE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADVERSE DRUG REACTION; AGRANULOCYTOSIS; ANEMIA; ANTIGEN PRESENTATION; ANTIGENICITY; APLASTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD CELL; CAT; CHOLESTATIC HEPATITIS; COVALENT BOND; DENDRITIC CELL; DOG; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG METABOLISM; EOSINOPHILIA; FIXED DRUG ERUPTION; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC DISEASE; IDIOSYNCRATIC ADVERSE DRUG REACTION; IMMUNE RESPONSE; IMMUNOGENICITY; LIVER CELL DAMAGE; LIVER INJURY; LUPUS LIKE SYNDROME; MACULOPAPULAR RASH; MOLECULAR WEIGHT; NATURAL KILLER CELL; NEVIRAPINE-INDUCED SKIN RASH; NONHUMAN; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; SKIN LUPUS ERYTHEMATOSUS; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VIRUS INFECTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; DRUG TOXICITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; RISK FACTOR;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG TOXICITY; HUMANS; LYMPHOCYTE ACTIVATION; RISK FACTORS; SULFONAMIDES; T-LYMPHOCYTES; VIRUS DISEASES;

MLCS; MLOWN;

EID: 84880763009     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.113.007450     Document Type: Review

References (313)

1. Adam J., Eriksson KK, Schnyder B, Fontana S, Pichler WJ, and Yerly D (2012) Avidity determines T-cell reactivity in abacavir hypersensitivity. Eur J Immunol 42:1706-1716.
2. Adam J., Pichler WJ, and Yerly D (2011) Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 71:701-707.
3. Aeby P., Sieber T, Beck H, Gerberick GF, and Goebel C (2009) Skin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J Invest Dermatol 129: 99-109.
4. Aithal G. P, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J., and Day CP (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440.
5. Akdis C. A and Akdis M (2009) Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123:735-748.
6. Aleksic M., Pease CK, Basketter DA, Panico M, Morris HR, and Dell A (2007) Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicol In Vitro 21:723-733.
7. Aleksic M., Pease CK, Basketter DA, Panico M, Morris HR, and Dell A (2008) Mass spectrometric identification of covalent adducts of the skin allergen 2,4-dinitro-1-chlorobenzene and model skin proteins. Toxicol In Vitro 22:1169-1176.
8. Aleksic M., Thain E, Roger D, Saib O, Davies M, Li J, Aptula A, and Zazzeroni R (2009) Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment. Toxicol Sci 108:401-411.
9. Alfirevic A., Gonzalez-Galarza F, Bell C, Martinsson K, Platt V, Bretland G, Evely J, Lichtenfels M., Cederbrant K, and French N, et al. (2012) In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med 4:51.
10. Alfirevic A., Stalford AC, Vilar FJ, Wilkins EG, Park BK, and Pirmohamed M (2003) Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity. Br J Clin Pharmacol 55:158-165.
11. Alfirevic A., Vilar FJ, Alsbou M, Jawaid A, Thomson W, Ollier WE, Bowman CE, Delrieu O., Park BK, and Pirmohamed M (2009) TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole. Pharmacogenomics 10:531-540.
12. Almeida C. A, Martin AM, Nolan D, Lucas A, Cameron PU, James I, Phillips E, and Mallal S (2008) Cytokine profiling in abacavir hypersensitivity patients. Antivir Ther 13:281-288.
13. Alvarez-Sánchez R., Basketter D, Pease C, and Lepoittevin JP (2003) Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI). Chem Res Toxicol 16:627-636.
14. Anderson R. J, Kudlacek PE, and Clemens DL (1998) Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact 109:53-67.
15. Aster R. H (2009) Molecular mimicry and immune thrombocytopenia. Blood 113: 3887-3888.
16. Aster R. H, Curtis BR, McFarland JG, and Bougie DW (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7:911-918.
17. Aucoin D. P, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, and Reidenberg MM (1985) Propylthiouracil-induced immune-mediated disease in the cat. J Pharmacol Exp Ther 234:13-18.
18. Baillie T. A and Slatter JG (1991) Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo. Acc Chem Res 24:264-270.
19. Baron J. M, Wiederholt T, Heise R, Merk HF, and Bickers DR (2008) Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr Med Chem 15:2258-2264.
20. Batchelor F. R, Dewdney JM, and Gazzard D (1965) Penicillin allergy: the formation of the penicilloyl determinant. Nature 206:362-364.
21. Bedard K., Smith S, and Cribb A (2000) Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction. Br J Dermatol 142:253-258.
22. Besser M., Vera J, Clark J, Chitnavis D, Beatty C, and Vassiliou G (2009) Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. Int J Lab Hematol 31:245-247.
23. Björnsson E. (2010) Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 32:3-13.
24. Björnsson E. and Olsson R (2005) Outcome and prognostic markers in severe druginduced liver disease. Hepatology 42:481-489.
25. Björnsson E., Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M., and Lindor K (2010) Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 51:2040-2048.
26. Borg F. A and Isenberg DA (2007) Syndromes and complications of interferon therapy. Curr Opin Rheumatol 19:61-66.
27. Bougie D. W, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J., and Aster RH (2002) Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 100:2071-2076.
28. Brander C., Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, and Pichler WJ (1995) Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 155:2670-2678.
29. Britschgi M., Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N., and Pichler WJ (2001) T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107:1433-1441.
30. Bukhari M. (2012) Drug-induced rheumatic diseases: a review of published case reports from the last two years. Curr Opin Rheumatol 24:182-186.
31. Burkhart C., von Greyerz S, Depta JP, Naisbitt DJ, Britschgi M, Park KB, and Pichler WJ (2001) Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br J Pharmacol 132:623-630.
32. Cacoub P., Musette P, Descamps V, Meyer O, Speirs C, Finzi L, and Roujeau JC (2011) The DRESS syndrome: a literature review. Am J Med 124:588-597.
33. Callan H. E, Jenkins RE, Maggs JL, Lavergne SN, Clarke SE, Naisbitt DJ, and Park BK (2009) Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Chem Res Toxicol 22:937-948.
34. Callen J. P (2001) Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 45:315-316.
35. Cameron H. A and Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed) 289: 410-412.
36. Carey M. A and van Pelt FN (2005) Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology 216:41-48.
37. Castrejon J. L, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, and Naisbitt DJ (2010a) Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol 125:411-418.
38. Castrejon J. L, Lavergne SN, El-Sheikh A, Farrell J, Maggs JL, Sabbani S, O'Neill PM, Park BK, and Naisbitt DJ (2010b) Metabolic and chemical origins of crossreactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives. Chem Res Toxicol 23:184-192.
39. Chalasani N. and Björnsson E (2010) Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 138:2246-2259.
40. Chalasani N., Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, and Rochon J; Drug-Induced Liver Injury Network (2008) Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924-1934.
41. Chalmers A., Thompson D, Stein HE, Reid G, and Patterson AC (1982) Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis. Ann Intern Med 97:659-663.
42. Chang C. and Gershwin ME (2011) Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf 34:357-374.
43. Chen P., Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, and Hsu YC, et al.; Taiwan SJS Consortium (2011) Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 364:1126-1133.
44. Chen X., Tharmanathan T, Mannargudi B, Gou H, and Uetrecht JP (2009) A study of the specificity of lymphocytes in nevirapine-induced skin rash. J Pharmacol Exp Ther 331:836-841.
45. Cheng L., You Q, Yin H, Holt M, Franklin C, and Ju C (2009) Effect of polyI:C cotreatment on halothane-induced liver injury in mice. Hepatology 49:215-226.
46. Cheng L., You Q, Yin H, Holt MP, and Ju C (2010) Involvement of natural killer T cells in halothane-induced liver injury in mice. Biochem Pharmacol 80:255-261.
47. Choi M. J, Kim HS, Park HJ, Park CJ, Lee JD, Lee JY, Kim HO, and Park YM (2010) Clinicopathologic manifestations of 36 korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature. Ann Dermatol 22:163-169.
48. Choquet-Kastylevsky G., Santolaria N, Tedone R, Aujoulat M, and Descotes J (2001) Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites. Toxicol Lett 119:183-192.
49. Christie G., Coleman JW, Newby S, McDiarmaid-Gordon A, Hampson JP, Breckenridge AM, and Park BK (1988) A survey of the prevalence of penicillin-specific IgG, IgM and IgE antibodies detected by ELISA and defined by hapten inhibition, in patients with suspected penicillin allergy and in healthy volunteers. Br J Clin Pharmacol 25:381-386.
50. Chung W. H, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, and Ho HC, et al. (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343-1350.
51. Clay K. D, Hanson JS, Pope SD, Rissmiller RW, Purdum PP 3rd, and Banks PM (2006) Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review. Ann Intern Med 144:415-420.
52. Costa M. F, Said NR, and Zimmermann B (2008) Drug-induced lupus due to antitumor necrosis factor alpha agents. Semin Arthritis Rheum 37:381-387.
53. Coulter E. M, Jenkinson C, Farrell J, Lavergne SN, Pease C, White A, Aleksic M, Basketter D., Williams DP, and King C, et al. (2010) Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in pphenylenediamine allergic patients and tolerant individuals. J Invest Dermatol 130:161-174.
54. Coulter E. M, Jenkinson C, Wu Y, Farrell J, Foster B, Smith A, McGuire C, Pease C, Basketter D., and King C, et al. (2008) Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base. J Invest Dermatol 128:897-905.
55. Creamer E., Galvin S, Dolan A, Sherlock O, Dimitrov BD, Fitzgerald-Hughes D, Thomas T., Walsh J, Moore J, and Smyth EG, et al. (2012) Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital. Am J Infect Control 40:411-415.
56. Cribb A. E, Nuss CE, Alberts DW, Lamphere DB, Grant DM, Grossman SJ, and Spielberg SP (1996) Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem Res Toxicol 9:500-507.
57. Cribb A. E and Spielberg SP (1992) Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 51:522-526.
58. Cribb A. E, Spielberg SP, and Griffin GP (1995) N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 23:406-414.
59. Czaja A. J (2011) Drug-induced autoimmune-like hepatitis. Dig Dis Sci 56:958-976.
60. Daftarian M. P, Filion LG, Cameron W, Conway B, Roy R, Tropper F, and Diaz-Mitoma F. (1995) Immune response to sulfamethoxazole in patients with AIDS. Clin Diagn Lab Immunol 2:199-204.
61. Dai R., Grammer SF, and Streilein JW (1993) Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. J Immunol 150: 59-66.
62. Dai R. and Streilein JW (1998) Naïve, hapten-specific human T lymphocytes are primed in vitro with derivatized blood mononuclear cells. J Invest Dermatol 110: 29-33.
63. Daly A. K (2012) Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annu Rev Pharmacol Toxicol 52:21-35.
64. de Araujo E, Dessirier V, Laprée G, Valeyrie-Allanore L, Ortonne N, Stathopoulos EN, Bagot M, Bensussan A, Mockenhaupt M, and Roujeau JC, et al. (2011) Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis. Exp Dermatol 20:107-112.
65. de Haan P, Bruynzeel DP, and van Ketel WG (1986) Onset of penicillin rashes: relation between type of penicillin administered and type of immune reactivity. Allergy 41:75-78.
66. de Latour RP, Visconte V, Takaku T, Wu C, Erie AJ, Sarcon AK, Desierto MJ, Scheinberg P., Keyvanfar K, and Nunez O, et al. (2010) Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood 116:4175-4184.
67. Descamps V., Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange M. J, Grossin M, and Navratil E, et al. (1997) Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137:605-608.
68. Dietz L., Esser PR, Schmucker SS, Goette I, Richter A, Schnölzer M, Martin SF, and Thierse HJ (2010) Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol Sci 117:336-347.
69. Divkovic M., Pease CK, Gerberick GF, and Basketter DA (2005) Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermat 53:189-200.
70. Donker A. J, Venuto RC, Vladutiu AO, Brentjens JR, and Andres GA (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol Immunopathol 30:142-155.
71. Downey A., Jackson C, Harun N, and Cooper A (2012) Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 66:995-1003.
72. Doyle A., Forbes G, and Kontorinis N (2011) Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report. J Crohn's Colitis 5:253-255.
73. El-Ghaiesh S., Monshi MM, Whitaker P, Jenkins R, Meng X, Farrell J, Elsheikh A, Peckham D., French N, and Pirmohamed M, et al. (2012) Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther 341:597-610.
74. Eliasson E. and Kenna JG (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573-582.
75. Elkon K. B and Wiedeman A (2012) Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 24:499-505.
76. Elsheikh A., Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, El-Ghaiesh S, Farrell J, Pichler WJ, Peckham D, Park BK, and Naisbitt DJ (2011) Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis. J Allergy Clin Immunol 127:1543-1551.
77. Elsheikh A., Lavergne SN, Castrejon JL, Farrell J, Wang H, Sathish J, Pichler WJ, Park B. K, and Naisbitt DJ (2010) Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. J Immunol 185:6448-6460.
78. Engler O. B, Strasser I, Naisbitt DJ, Cerny A, and Pichler WJ (2004) A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Toxicology 197:47-56.
79. Esser P. R, Wölfle U, Dürr C, von Loewenich FD, Schempp CM, Freudenberg MA, Jakob T., and Martin SF (2012) Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS ONE 7:e41340.
80. Eyanagi R., Toda A, Imoto M, Uchiyama H, Ishii Y, Kuroki H, Kuramoto Y, Soeda S, and Shimeno H (2012) Covalent binding of nitroso-sulfonamides to glutathione Stransferase in guinea pigs with delayed type hypersensitivity. Int Immunopharmacol 12:694-700.
81. Eyerich K., Pennino D, Scarponi C, Foerster S, Nasorri F, Behrendt H, Ring J, Traidl-Hoffmann C., Albanesi C, and Cavani A (2009) IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123:59-66.
82. Eyerich S., Eyerich K, Cavani A, and Schmidt-Weber C (2010) IL-17 and IL-22: siblings, not twins. Trends Immunol 31:354-361.
83. Eyerich S., Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, Grosber M, Pfab F, Schmidt-Weber CB, and Mempel M, et al. (2011) Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 365:231-238.
84. Fan H. and Cook JA (2004) Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10:71-84.
85. Farrell J., Jenkinson C, Lavergne SN, Maggs JL, Kevin Park B, and Naisbitt DJ (2009) Investigation of the immunogenicity of p-phenylenediamine and Bandrowski's base in the mouse. Toxicol Lett 185:153-159.
86. Farrell J., Naisbitt DJ, Drummond NS, Depta JP, Vilar FJ, Pirmohamed M, and Park BK (2003) Characterization of sulfamethoxazole and sulfamethoxazole metabolitespecific T-cell responses in animals and humans. J Pharmacol Exp Ther 306: 229-237.
87. Faulkner L., Martinsson K, Santoyo-Castelazo A, Cederbrant K, Schuppe-Koistinen I, Powell H., Tugwood J, Naisbitt DJ, and Park BK (2012) The development of in vitro culture methods to characterize primary T-cell responses to drugs. Toxicol Sci 127: 150-158.
88. Friedmann P. S, Moss C, Shuster S, and Simpson JM (1983) Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 53:709-715.
89. Fujimoto K., Kumagai K, Ito K, Arakawa S, Ando Y, Oda S, Yamoto T, and Manabe S (2009) Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol 37:193-200.
90. Furst S. M and Gandolfi AJ (1997) Interaction of lymphocytes with Kupffer cells from halothane-exposed guinea pigs. Int Arch Allergy Immunol 114:46-53.
91. Furst S. M, Luedke D, and Gandolfi AJ (1997a) Kupffer cells from halothaneexposed guinea pigs carry trifluoroacetylated protein adducts. Toxicology 120: 119-132.
92. Furst S. M, Luedke D, Gaw HH, Reich R, and Gandolfi AJ (1997b) Demonstration of a cellular immune response in halothane-exposed guinea pigs. Toxicol Appl Pharmacol 143:245-255.
93. Garratty G. (2012) Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 11:635-642.
94. Gerberick F., Aleksic M, Basketter D, Casati S, Karlberg AT, Kern P, Kimber I, Lepoittevin J. P, Natsch A, and Ovigne JM, et al. (2008) Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim 36:215-242.
95. Gerberick G. F, Vassallo JD, Foertsch LM, Price BB, Chaney JG, and Lepoittevin JP (2007) Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol Sci 97:417-427.
96. Gerson S. L and Meltzer H (1992) Mechanisms of clozapine-induced agranulocytosis. Drug Saf 7 (Suppl 1):17-25.
97. Giannone L., Kugler JW, and Krantz SB (1987) Pure red cell aplasia associated with administration of sustained-release procainamide. Arch Intern Med 147: 1179-1180.
98. Gill H. J, Maggs JL, Madden S, Pirmohamed M, and Park BK (1996) The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole. Br J Clin Pharmacol 42:347-353.
99. Grönhagen C. M, Fored CM, Granath F, and Nyberg F (2012a) Increased risk of cancer among 3663 patients with cutaneous lupus erythematosus: a Swedish nationwide cohort study. Br J Dermatol 166:1053-1059.
100. Grönhagen C. M, Fored CM, Linder M, Granath F, and Nyberg F (2012b) Subacute cutaneous lupus erythematosus and its association with drugs: a populationbased matched case-control study of 234 patients in Sweden. Br J Dermatol 167: 296-305.
101. Harris H. E, Andersson U, and Pisetsky DS (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8:195-202.
102. Hashizume H. and Takigawa M (2005) Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol 85:47-50.
103. Hashizume H., Takigawa M, and Tokura Y (2002) Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 168:5359-5368.
104. Hetherington S., Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K., Handley A, and Dow DJ, et al. (2002) Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 359:1121-1122.
105. Hitzler M., Majdic O, Heine G, Worm M, Ebert G, Luch A, and Peiser M (2012) Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy. PLoS ONE 7: e46776.
106. Hollander S. M, Joo SS, and Wedner HJ (2011) Factors that predict the success of cyclosporine treatment for chronic urticaria. Ann Allergy Asthma Immunol 107: 523-528.
107. Hopkins J. E, Naisbitt DJ, Humphreys N, Dearman RJ, Kimber I, and Park BK (2005) Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Toxicology 206:221-231.
108. Hunziker T., Künzi UP, Braunschweig S, Zehnder D, and Hoigné R (1997) Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 52:388-393.
109. Hussaini S. H and Farrington EA (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 6:673-684.
110. Illing P. T, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L., Gras S, and Williamson NA, et al. (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486:554-558.
111. Jaeschke H., Williams CD, Ramachandran A, and Bajt ML (2012) Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 32:8-20.
112. Jahn S., Faber H, Zazzeroni R, and Karst U (2012) Electrochemistry/liquid chromatography/mass spectrometry to demonstrate irreversible binding of the skin allergen p-phenylenediamine to proteins. Rapid Commun Mass Spectrom 26: 1415-1425.
113. Jain K. K (1991) Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Saf 6:350-360.
114. James L. K, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, Jacobson MR, Kimber I, Till SJ, and Durham SR (2011) Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 127:509-516.
115. Jenkins R. E, Kitteringham NR, Goldring CE, Dowdall SM, Hamlett J, Lane CS, Boerma J. S, Vermeulen NP, and Park BK (2008) Glutathione-S-transferase pi as a model protein for the characterisation of chemically reactive metabolites. Proteomics 8:301-315.
116. Jenkins R. E, Meng X, Elliott VL, Kitteringham NR, Pirmohamed M, and Park BK (2009) Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin Appl 3:720-729.
117. Jenkinson C., Jenkins RE, Aleksic M, Pirmohamed M, Naisbitt DJ, and Park BK (2010) Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein. J Invest Dermatol 130:732-742.
118. Jenkinson C., Jenkins RE, Maggs JL, Kitteringham NR, Aleksic M, Park BK, and Naisbitt DJ (2009) A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine. Chem Res Toxicol 22: 1172-1180.
119. Joffre O. P, Segura E, Savina A, and Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12:557-569.
120. Jurado-Palomo J., Cabañas R, Prior N, Bobolea ID, Fiandor-Román AM, López-Serrano M. C, Quirce S, and Bellón T (2010) Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillintazobactam: two case reports. J Investig Allergol Clin Immunol 20:433-436.
121. Kalgutkar A. S and Dalvie DK (2012) Drug discovery for a new generation of covalent drugs. Expert Opin Drug Discov 7:561-581.
122. Kalish R. S and Askenase PW (1999) Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J Allergy Clin Immunol 103:192-199.
123. Kano Y., Hirahara K, Mitsuyama Y, Takahashi R, and Shiohara T (2007) Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62:1439-1444.
124. Kano Y., Hiraharas K, Sakuma K, and Shiohara T (2006) Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155:301-306.
125. Kardaun S. H, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, and Roujeau JC (2007) Variability in the clinical pattern of cutaneous sideeffects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156:609-611.
126. Keane N., Lucas A, Netto J, Almeida CA, Martin AM, Marriott D, Kelleher A, Phillips E, Nolan D, and Mallal S (2007) Use of the ELISpot assay to detect abacavir-and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions, in 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 2007 Jul 22-25; Sydney, NSW, Australia.
127. Keisu M. and Andersson TB (2010) Drug-induced liver injury in humans: the case of ximelagatran. Handb Exp Pharmacol 196:407-418.
128. Keller M., Lerch M, Britschgi M, Tâche V, Gerber BO, Lüthi M, Lochmatter P, Kanny G, Bircher AJ, and Christiansen C, et al. (2010) Processing-dependent and-independent pathways for recognition of iodinated contrast media by specific human T cells. Clin Exp Allergy 40:257-268.
129. Khan F. D, Vyas PM, Gaspari AA, and Svensson CK (2007) Effect of arylhydroxylamine metabolites of sulfamethoxazole and dapsone on stress signal expression in human keratinocytes. J Pharmacol Exp Ther 323:771-777.
130. Kindmark A., Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, Carlsson S., Cederbrant KE, Gibson NJ, and Armstrong M, et al. (2008) Genomewide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 8:186-195.
131. Kish D. D, Gorbachev AV, and Fairchild RL (2012) IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response. J Immunol 188:1761-1771.
132. Kitteringham N. R, Maggs JL, Newby S, and Park BK (1985) Drug-protein conjugates-VIII. The metabolic fate of the dinitrophenyl hapten conjugated to albumin. Biochem Pharmacol 34:1763-1771.
133. Ko T. M, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, and Hung SI (2011) Shared and restricted T-cell receptor use is crucial for carbamazepineinduced Stevens-Johnson syndrome. J Allergy Clin Immunol 128:1266-1276.
134. Kuechler P. C, Britschgi M, Schmid S, Hari Y, Grabscheid B, and Pichler WJ (2004) Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59:613-622.
135. Kumar R., Ferez M, Swamy M, Arechaga I, Rejas MT, Valpuesta JM, Schamel WW, Alarcon B., and van Santen HM (2011) Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes. Immunity 35:375-387.
136. Kurian J. R, Bajad SU, Miller JL, Chin NA, and Trepanier LA (2004) NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther 311: 1171-1178.
137. Lafaye P. and Lapresle C (1988) Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients. J Clin Invest 82:7-12.
138. Landsteiner K. and Jacobs J (1935) Studies on the sensitization of animals with simple chemical compounds. J Exp Med 61:643-656.
139. Lanzavecchia A. (2007) Pillars article: Antigen-specific interaction between T and B cells. 1985. J Immunol 179:7206-7208.
140. Lavergne S. N, Wang H, Callan HE, Park BK, and Naisbitt DJ (2009) "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigenpresenting cells. J Pharmacol Exp Ther 331:372-381.
141. Lavergne S. N, Whitaker P, Peckham D, Conway S, Park BK, and Naisbitt DJ (2010) Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Chem Res Toxicol 23:1009-1011.
142. Lecoeur S., André C, and Beaune PH (1996) Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a threesite conformational epitope on cytochrome P4502C9. Mol Pharmacol 50:326-333.
143. Lerch M., Keller M, Britschgi M, Kanny G, Tache V, Schmid DA, Beeler A, Gerber BO, Luethi M., and Bircher AJ, et al. (2007) Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 119:1529-1536.
144. Levine B. B (1960) Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin G and its degradation products. J Exp Med 112:1131-1156.
145. Levine B. B and Redmond AP (1969) Minor haptenic determinant-specific reagins of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 35:445-455.
146. Lezo A., Biasi F, Massarenti P, Calabrese R, Poli G, Santini B, and Bignamini E (2013) Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels? J Cyst Fibros 12:35-41.
147. Lonjou C., Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck J. N, Sidoroff A, and de Toma C, et al.; RegiSCAR study group (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99-107.
148. Lonjou C., Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, and Mockenhaupt M, et al.; RegiSCAR Group (2006) A marker for Stevens-Johnson syndrome.: ethnicity matters. Pharmacogenomics J 6:265-268.
149. Lucena M. I, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M., Bruguera M, Hallal H, Robles-Diaz M, and Rodriguez-González JF, et al.; Spanish Group for the Study of Drug-Induced Liver Disease (2009) Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 49:2001-2009.
150. Lucena M. I, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F., Donaldson PT, and Stephens C, et al.; Spanish DILI Registry;; EUDRAGENE;; DILIN;; DILIGEN;; International SAEC (2011) Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141:338-347.
151. Luyendyk J. P, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, and Roth RA (2003) Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther 307:9-16.
152. Maddrey W. C and Boitnott JK (1973) Isoniazid hepatitis. Ann Intern Med 79:1-12.
153. Maggs J. L, Kitteringham NR, Grabowski PS, and Park BK (1986) Drug-protein conjugates-X. The role of protein conjugation in the disposition of dinitrofluorobenzene. Biochem Pharmacol 35:505-513.
154. Mallal S., Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C., and Maxwell D, et al. (2002) Association between presence of HLAB* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reversetranscriptase inhibitor abacavir. Lancet 359:727-732.
155. Mallal S., Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S., Kozyrev O, and Cid JF, et al.; PREDICT-1 Study Team (2008) HLAB* 5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568-579.
156. Manchanda T., Hess D, Dale L, Ferguson SG, and Rieder MJ (2002) Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol Pharmacol 62: 1011-1026.
157. Maria V. A and Victorino RM (1997) Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 41:534-540.
158. Martin A. M, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, McCluskey J, Phillips E., Landay A, and Mallal S (2007) Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS 21:1233-1244.
159. Martin S., Ortmann B, Pflugfelder U, Birsner U, and Weltzien HU (1992) Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J Immunol 149:2569-2575.
160. Martin S., von Bonin A, Fessler C, Pflugfelder U, and Weltzien HU (1993) Structural complexity of antigenic derminants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes. J Immunol 151:678-687.
161. Martin S. and Weltzien HU (1994) T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 104:10-16.
162. Martin S. F, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas J. F, Keller M, and Pichler WJ, et al. (2010) T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci 67:4171-4184.
163. Martin S. F, Esser PR, Weber FC, Jakob T, Freudenberg MA, Schmidt M, and Goebeler M (2011) Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66:1152-1163.
164. Mathelier-Fusade P. (2006) Drug-induced urticarias. Clin Rev Allergy Immunol 30: 19-23.
165. Mauri-Hellweg D., Bettens F, Mauri D, Brander C, Hunziker T, and Pichler WJ (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155:462-472.
166. McCormack M., Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, Carrington M, Sills G. J, Marson T, Jia X, and de Bakker PI, et al. (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 364:1134-1143.
167. McCormack M., Urban TJ, Shianna KV, Walley N, Pandolfo M, Depondt C, Chaila E, O'Conner GD, Kasperaviciute D, and Radtke RA, et al. (2012) Genome-wide mapping for clinically relevant predictors of lamotrigine-and phenytoin-induced hypersensitivity reactions. Pharmacogenomics 13:399-405.
168. McGill M. R, Sharpe MR, Williams CD, Taha M, Curry SC, and Jaeschke H (2012) The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 122: 1574-1583.
169. McLain G. E, Sipes IG, and Brown BR Jr (1979) An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia. Anesthesiology 51:321-326.
170. Meng X., Jenkins RE, Berry NG, Maggs JL, Farrell J, Lane CS, Stachulski AV, French N. S, Naisbitt DJ, and Pirmohamed M, et al. (2011) Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther 338:841-849.
171. Mennicke M., Zawodniak A, Keller M, Wilkens L, Yawalkar N, Stickel F, Keogh A, Inderbitzin D., Candinas D, and Pichler WJ (2009) Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 9:2197-2202.
172. Meschkat E., Barratt MD, and Lepoittevin J (2001a) Studies of the chemical selectivity of hapten, reactivity, and skin sensitization potency. 1. Synthesis and studies on the reactivity toward model nucleophiles of the (13)C-labeled skin sensitizers hex-1-ene-and hexane-1,3-sultones. Chem Res Toxicol 14:110-117.
173. Meschkat E., Barratt MD, and Lepoittevin J (2001b) Studies of the chemical selectivity of hapten, reactivity, and skin sensitization potency. 2. NMR studies of the covalent binding of the (13)c-labeled skin sensitizers 2-[13C]-and 3-[13C]hex-1-ene-and 3-[13C]hexane-1,3-sultones to human serum albumin. Chem Res Toxicol 14:118-126.
174. Mitsuyasu R., Groopman J, and Volberding P (1983) Cutaneous reaction to trimethoprimsulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med 308: 1535-1536.
175. Moeschlin S. and Wagner K (1952) [Agranulocytosis due to the occurrence of leucocyte-agglutinins; pyramidon and cold agglutinins]. Acta Haematol 8:29-41.
176. Monshi M., Faulkner L, Gibson A, Jenkins RE, Farrell J, Earnshaw CJ, Alfirevic A, Cederbrant K., Daly AK, and French N, et al. (2013) HLA-B*57:01-restricted activation of drug-specific T-cells provides the immunological basis for flucloxacillininduced liver injury. Hepatology 57:727-739.
177. Münz C. (2012) Antigen processing for MHC class II presentation via autophagy. Front Immunol 3:9 DOI: 10.3389/fimmu.2012.00009.
178. Naisbitt D. J, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M., and Park BK (2003a) Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drugspecific T cell clones. Mol Pharmacol 63:732-741.
179. Naisbitt D. J, Farrell J, Chamberlain PJ, Hopkins JE, Berry NG, Pirmohamed M, and Park BK (2005) Characterization of the T-cell response in a patient with phenindione hypersensitivity. J Pharmacol Exp Ther 313:1058-1065.
180. Naisbitt D. J, Farrell J, Gordon SF, Maggs JL, Burkhart C, Pichler WJ, Pirmohamed M, and Park BK (2002) Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol 62:628-637.
181. Naisbitt D. J, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick D. W, Pichler WJ, and Pirmohamed M, et al. (2003b) Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 111: 1393-1403.
182. Naisbitt D. J, Gordon SF, Pirmohamed M, Burkhart C, Cribb AE, Pichler WJ, and Park BK (2001) Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol 133:295-305.
183. Naisbitt D. J, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, and Park BK (1999) Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 126:1393-1407.
184. Nakayama S., Atsumi R, Takakusa H, Kobayashi Y, Kurihara A, Nagai Y, Nakai D, and Okazaki O (2009) A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab Dispos 37:1970-1977.
185. Nakamura H., Okada A, Kawakami A, Yamasaki S, Ida H, Motomura M, Imanishi D, and Eguchi K (2010) Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. Rheumatol Int 30:1643-1645.
186. Nassif A., Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, and Roujeau JC (2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114:1209-1215.
187. Neefjes J., Jongsma ML, Paul P, and Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823-836.
188. Neftel K. A, Woodtly W, Schmid M, Frick PG, and Fehr J (1986) Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) 292:721-723.
189. Ng W., Lobach AR, Zhu X, Chen X, Liu F, Metushi IG, Sharma A, Li J, Cai P, and Ip J, et al. (2012) Animal models of idiosyncratic drug reactions. Adv Pharmacol 63: 81-135.
190. Niihara H., Kakamu T, Fujita Y, Kaneko S, and Morita E (2012) HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population. J Dermatol 39:594-601.
191. Norcross M. A, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies D. H, McMurtrey C, and Vernon S, et al. (2012) Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLAassociated drug hypersensitivity. AIDS 26:F21-F29.
192. Ong M. M, Latchoumycandane C, and Boelsterli UA (2007) Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci 97:205-213.
193. Orman E. S, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, and Hayashi PH (2011) Clinical and histopathologic features of fluoroquinoloneinduced liver injury. Clin Gastroenterol Hepatol 9:517-523.
194. Ostrov D. A, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S., Jakoncic J, and de Oliveira CA, et al. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA 109:9959-9964.
195. Padovan E., Bauer T, Tongio MM, Kalbacher H, and Weltzien HU (1997) Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 27:1303-1307.
196. Paquet P. and Piérard GE (2010a) New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited. Drug Saf 33:189-212.
197. Paquet P. and Piérard GE (2010b) Topical treatment options for drug-induced toxic epidermal necrolysis (TEN). Expert Opin Pharmacother 11:2447-2458.
198. Park B. K, Boobis A, Clarke S, Goldring CE, Jones D, Kenna JG, Lambert C, Laverty HG, Naisbitt DJ, and Nelson S, et al. (2011) Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov 10:292-306.
199. Park B. K, Pirmohamed M, and Kitteringham NR (1998) Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 11:969-988.
200. Pavlos R., Mallal S, and Phillips E (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 13:1285-1306.
201. Pennino D., Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, Garcovich S, Traidl-Hoffmann C., Albanesi C, and Cavani A (2010) IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 184:4880-4888.
202. Pereira F. A, Mudgil AV, and Rosmarin DM (2007) Toxic epidermal necrolysis. J Am Acad Dermatol 56:181-200.
203. Pessayre D., Fromenty B, Berson A, Robin MA, Lettéron P, Moreau R, and Mansouri A (2012) Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 44:34-87.
204. Peyrière H., Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, and Hillaire-Buys D; Network of the French Pharmacovigilance Centers (2006) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 155:422-428.
205. Codrea Tigaran S, Sidenius P, and Dam M (2005) Lamotrigine-induced rash-worth a rechallenge. Acta Neurol Scand 111:191-194.
206. Phillips E. and Mallal S (2009) Successful translation of pharmacogenetics into the clinic: the abacavir example. Mol Diagn Ther 13:1-9.
207. Phillips E. J, Chung WH, Mockenhaupt M, Roujeau JC, and Mallal SA (2011) Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol 127(3, Suppl)S60-S66.
208. Phillips E. J, Wong GA, Kaul R, Shahabi K, Nolan DA, Knowles SR, Martin AM, Mallal S. A, and Shear NH (2005) Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 19:979-981.
209. Picard D., Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, and Toubert A, et al. (2010) Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2:46ra62.
210. Pichler W. J (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139: 683-693.
211. Pichler W. J (2005) Direct T-cell stimulations by drugs-bypassing the innate immune system. Toxicology 209:95-100.
212. Pickard C., Louafi F, McGuire C, Lowings K, Kumar P, Cooper H, Dearman RJ, Cumberbatch M., Kimber I, and Healy E, et al. (2009) The cutaneous biochemical redox barrier: a component of the innate immune defenses against sensitization by highly reactive environmental xenobiotics. J Immunol 183:7576-7584.
213. Pickard C., Smith AM, Cooper H, Strickland I, Jackson J, Healy E, and Friedmann PS (2007) Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene. J Invest Dermatol 127:630-637.
214. Piérard G. E and Paquet P (2010) Facing up to toxic epidermal necrolysis. Expert Opin Pharmacother 11:2443-2446.
215. Pirmohamed M., Alfirevic A, Vilar J, Stalford A, Wilkins EG, Sim E, and Park BK (2000) Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics 10: 705-713.
216. Preckel T., Grimm R, Martin S, and Weltzien HU (1997) Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J Exp Med 185:1803-1813.
217. Proctor W. R, Chakraborty M, Chea LS, Morrison JC, Berkson JD, Semple K, Bourdi M, and Pohl LR (2012) Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology DOI: 10.1002/hep.26196.
218. Pullen H., Wright N, and Murdoch JM (1967) Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 2:1176-1178.
219. Pumford N. R, Myers TG, Davila JC, Highet RJ, and Pohl LR (1993) Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. Chem Res Toxicol 6:147-150.
220. Reilly T. P, Lash LH, Doll MA, Hein DW, Woster PM, and Svensson CK (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 114:1164-1173.
221. Richardson B. (2003) DNA methylation and autoimmune disease. Clin Immunol 109: 72-79.
222. Richardson B., Sawalha AH, Ray D, and Yung R (2012) Murine models of lupus induced by hypomethylated T cells (DNA hypomethylation and lupus.). Methods Mol Biol 900:169-180.
223. Robin M. A, Maratrat M, Le Roy M, Le Breton FP, Bonierbale E, Dansette P, Ballet F, Mansuy D., and Pessayre D (1996) Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J Clin Invest 6:1471-1480.
224. Rodriguez-Pena R., Lopez S, Mayorga C, Antunez C, Fernandez TD, Torres MJ, and Blanca M (2006) Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 118:949-956.
225. Roth R. A, Luyendyk JP, Maddox JF, and Ganey PE (2003) Inflammation and drug idiosyncrasy-is there a connection? J Pharmacol Exp Ther 307:1-8.
226. Roujeau J. C (2005) Clinical heterogeneity of drug hypersensitivity. Toxicology 209: 123-129.
227. Roujeau J. C, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, and Vaillant L, et al. (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127:1333-1338.
228. Rozieres A., Hennino A, Rodet K, Gutowski MC, Gunera-Saad N, Berard F, Cozon G, Bienvenu J., and Nicolas JF (2009) Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64:534-542.
229. Sacco J. C and Trepanier LA (2010) Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction. Pharmacogenet Genomics 20:26-37.
230. Saito N., Yoshioka N, Abe R, Qiao H, Fujita Y, Hoshina D, Suto A, Kase S, Kitaichi N, Ozaki M., et al. (2013) Stevens-Johnson Syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients. J Allergy Clin Immunol 131:434-441.
231. Sanderson J. P, Naisbitt DJ, Farrell J, Ashby CA, Tucker MJ, Rieder MJ, Pirmohamed M, Clarke SE, and Park BK (2007) Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 178: 5533-5542.
232. Satoguina J. S, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, and Hoerauf A (2008) Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 38:3101-3113.
233. Schlapbach C., Zawodniak A, Irla N, Adam J, Hunger RE, Yerly D, Pichler WJ, and Yawalkar N (2011) NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions. Allergy 66:1469-1476.
234. Schnyder B., Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, and Pichler WJ (2000) Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164:6647-6654.
235. Schnyder B., Mauri-Hellweg D, Zanni M, Bettens F, and Pichler WJ (1997) Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 100:136-141.
236. Sharma A. M, Klarskov K, and Uetrecht J (2013) Nevirapine bioactivation and covalent binding in the skin. Chem Res Toxicol DOI: 10.1021/tx3004938.
237. Sharma A. M, Li Y, Novalen M, Hayes MA, and Uetrecht J (2012) Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury. Chem Res Toxicol 25:1708-1719.
238. Sharp A. A (1963) Chloramphenicol-induced blood dyscrasias: analysis of 40 cases. BMJ 1:735-736.
239. Shear N. H and Spielberg SP (1988) Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82:1826-1832.
240. Shenton J. M, Popovic M, Chen J, Masson MJ, and Uetrecht JP (2005) Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. Chem Res Toxicol 18:1799-1813.
241. Shenton J. M, Teranishi M, Abu-Asab MS, Yager JA, and Uetrecht JP (2003) Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapineinduced skin rash in the rat. Chem Res Toxicol 16:1078-1089.
242. Shi Y., Evans JE, and Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-521.
243. Shiohara T. (2009) Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 9:316-321.
244. Shiohara T., Iijima M, Ikezawa Z, and Hashimoto K (2007) The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156:1083-1084.
245. Shiohara T. and Kano Y (2007) A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33:124-133.
246. Shiohara T., Kano Y, Takahashi R, Ishida T, and Mizukawa Y (2012) Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 97:122-138.
247. Sieben S., Kawakubo Y, Al Masaoudi T, Merk HF, and Blömeke B (2002) Delayedtype hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 109:1005-1011.
248. Singer J. B, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, Wright TM, Meyer J, and Paulding CA (2010) A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 42:711-714.
249. Sloand E., Kim S, Maciejewski JP, Tisdale J, Follmann D, and Young NS (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100:1185-1191.
250. Spraggs C. F, Budde LR, Briley LP, Bing N, Cox CJ, King KS, Whittaker JC, Mooser VE, Preston AJ, and Stein SH, et al. (2011) HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol 29:667-673.
251. Stewart J. D, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB, Fontana RJ, Day CP, and Chinnery PF (2010) Polymerase g gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52:1791-1796.
252. Summan M. and Cribb AE (2002) Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells. Chem Biol Interact 142:155-173.
253. Suzuki Y., Inagi R, Aono T, Yamanishi K, and Shiohara T (1998) Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134:1108-1112.
254. Suzuki Y. and Ra C (2009) Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgEdependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. J Pharmacol Sci 110:237-244.
255. Syn W. K, Naisbitt DJ, Holt AP, Pirmohamed M, and Mutimer DJ (2005) Carbamazepine-induced acute liver failure as part of the DRESS syndrome. Int J Clin Pract 59:988-991.
256. Takahashi R., Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, and Shiohara T (2009) Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182:8071-8079.
257. Tamura Y., Torigoe T, Kukita K, Saito K, Okuya K, Kutomi G, Hirata K, and Sato N (2012) Heat-shock proteins as endogenous ligands building a bridge between innate and adaptive immunity. Immunotherapy 4:841-852.
258. Tang Y. H, Mockenhaupt M, Henry A, Bounoua M, Naldi L, Le Gouvello S, Bensussan A, and Roujeau JC (2012) Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis. Clin Exp Allergy 42:248-254.
259. Temple R. (2006) Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 15:241-243.
260. Tesfa D., Keisu M, and Palmblad J (2009) Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 84:428-434.
261. Tesfa D. and Palmblad J (2011) Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms. Expert Rev Hematol 4: 619-625.
262. Tewary P., Yang D, de la Rosa G, Li Y, Finn MW, Krensky AM, Clayberger C, and Oppenheim JJ (2010) Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 116:3465-3474.
263. Tohyama M. and Hashimoto K (2012) Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr Opin Allergy Clin Immunol 12: 376-382.
264. Tohyama M., Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, and Hashimoto K (1998) Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134:1113-1117.
265. Torres M. J, Gonzalez FJ, Mayorga C, Fernandez M, Juarez C, Romano A, and Blanca M (1997) IgG and IgE antibodies in subjects allergic to penicillins recognize different parts of the penicillin molecule. Int Arch Allergy Immunol 113:342-344.
266. Tournade H., Pelletier L, Pasquier R, Vial MC, Mandet C, and Druet P (1990) Dpenicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-induced autoimmunity. J Immunol 144:2985-2991.
267. Trepanier L. A (2004) Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 27:129-138.
268. Uetrecht J. (2005) Current trends in drug-induced autoimmunity. Autoimmun Rev 4: 309-314.
269. Uetrecht J. (2007) Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 47:513-539.
270. Uetrecht J. (2008) Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 21:84-92.
271. Uetrecht J. (2009a) Immune-mediated adverse drug reactions. Chem Res Toxicol 22: 24-34.
272. Uetrecht J. (2009b) Immunoallergic drug-induced liver injury in humans. Semin Liver Dis 29:383-392.
273. Uetrecht J. P, Freeman RW, and Woosley RL (1981a) The implications of procainamide metabolism to its induction of lupus. Arthritis Rheum 24:994-1003.
274. Uetrecht J. P and Woosley RL (1981) Acetylator phenotype and lupus erythematosus. Clin Pharmacokinet 6:118-134.
275. Uetrecht J. P, Woosley RL, Freeman RW, Sweetman BJ, and Oates JA (1981b) Metabolism of procainamide in the perfused rat liver. Drug Metab Dispos 9:183-187.
276. Um S. J, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, and Lee MK (2010) Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 20:556-562.
277. Valeyrie-Allanore L., Sassolas B, and Roujeau JC (2007) Drug-induced skin, nail and hair disorders. Drug Saf 30:1011-1030.
278. van der Ven AJ, Koopmans PP, Vree TB, and van der Meer JW (1994a) Drug intolerance in HIV disease. J Antimicrob Chemother 34:1-5.
279. van der Ven AJ, Mantel MA, Vree TB, Koopmans PP, and van der Meer JW (1994b) Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. Br J Clin Pharmacol 38:147-150.
280. van der Ven AJAM and Boers GHJ (1997) Oxidative stress in immunodeficiency. Eur J Clin Invest 27:731-732.
281. van Neerven RJ, Wikborg T, Lund G, Jacobsen B, Brinch-Nielsen A, Arnved J, and Ipsen H (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163:2944-2952.
282. Vocanson M., Cluzel-Tailhardat M, Poyet G, Valeyrie M, Chavagnac C, Levarlet B, Courtellemont P., Rozières A, Hennino A, and Nicolas JF (2008) Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens. J Invest Dermatol 128:2119-2122.
283. Vonakis B. M and Saini SS (2008) New concepts in chronic urticaria. Curr Opin Immunol 20:709-716.
284. Vyas P. M, Roychowdhury S, Khan FD, Prisinzano TE, Lamba JK, Schuetz EG, Blaisdell J., Goldstein JA, Munson KL, Hines RN, and Svensson C (2006a) Enzymemediated protein haptenation of dapsone and sulfamethoxaozle in human keratinocytes: I. Expression and role of cytochromes P450. J Pharmacol Exp Ther 319: 418-496
285. Vyas P. M, Roychowdhury S, Koukouritaki SB, Hines RN, Krueger SK, Williams DE, Nauseef W. M, and Svensson CK (2006b) Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygeanses and peroxidases. J Pharmacol Exp Ther 319: 497-505.
286. Waldhauser L. and Uetrecht J (1996) Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Toxicology 114:155-162.
287. Wallerstein R. O, Condit PK, Kasper CK, Brown JW, and Morrison FR (1969) Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 208: 2045-2050.
288. Walmsley S. L, Winn LM, Harrison ML, Uetrecht JP, and Wells PG (1997) Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIVinfected patients: toxicological and pathological implications. AIDS 11:1689-1697.
289. Walsh S. A and Creamer D (2011) Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 36:6-11.
290. Warbrick E. V, Dearman RJ, Lea LJ, Basketter DA, and Kimber I (1999) Local lymph node assay responses to paraphenylenediamine: intra-and inter-laboratory evaluations. J Appl Toxicol 19:255-260.
291. Warkentin T. E (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535-555.
292. Warkentin T. E and Kelton JG (2001) Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135:502-506.
293. Watanabe H., Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann PS, French L. E, and Gaide O (2008) Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol 180: 5826-5832.
294. Watkins P. B (2005) Idiosyncratic liver injury: challenges and approaches. Toxicol Pathol 33:1-5.
295. Watkins P. B, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, and Maddrey W (2011) Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 34:243-252.
296. Watts C. and Lanzavecchia A (1993) Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 178:1459-1463.
297. Wei C. Y, Chung WH, Huang HW, Chen YT, and Hung SI (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129:1562-1569.
298. Whitaker P., Meng X, Lavergne SN, El-Ghaiesh S, Monshi M, Earnshaw C, Peckham D, Gooi J, Conway S, and Pirmohamed M, et al. (2011) Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J Immunol 187:200-211.
299. Wiik A. (2008) Drug-induced vasculitis. Curr Opin Rheumatol 20:35-39.
300. Williams V. L and Cohen PR (2011) TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 50:619-625.
301. Wolkenstein P., Loriot MA, Flahault A, Cadilhac M, Caumes E, Eliaszewicz M, Beaune P., Roujeau JC, and Chosidow O; Epitox Group (2005) Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides. J Invest Dermatol 125:1080-1082.
302. Wu Y., Farrell J, Pirmohamed M, Park BK, and Naisbitt DJ (2007) Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol 119: 973-981.
303. Wu Y., Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, and Pichler WJ, et al. (2006) Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 118:233-241.
304. Yawalkar N. and Pichler WJ (2001) Pathogenesis of drug-induced exanthema. Int Arch Allergy Immunol 124:336-338.
305. You Q., Cheng L, and Ju C (2010) Generation of T cell responses targeting the reactive metabolite of halothane in mice. Toxicol Lett 194:79-85.
306. You Q., Cheng L, Reilly TP, Wegmann D, and Ju C (2006) Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 44:1421-1431.
307. Yun J., Adam J, Yerly D, and Pichler WJ (2012) Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy 67: 1338-1346.
308. Young N. and Alter BP (1994) Aplastic Anemia: Acquired and Inherited, W. B. Saunders Company, Philadelphia. Young N. S (2002) Acquired aplastic anemia. Ann Intern Med 136:534-546.
309. Young N. S, Calado RT, and Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509-2519.
310. Young N. S, Scheinberg P, and Calado RT (2008) Aplastic anemia. Curr Opin Hematol 15:162-168.
311. Zhang Q., Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, and Hauser CJ (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104-107.
312. Zhu X., Li J, Liu F, and Uetrecht JP (2011) Involvement of T helper 17 cells in Dpenicillamine-induced autoimmune disease in Brown Norway rats. Toxicol Sci 120: 331-338.
313. Zimmerman H. (1999) Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver, Lippincott Williams & Wilkins, Philadelphia.